Indian company seeks US approval for generic AIDS drugs.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000191:economics; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use; D003906:Developing Countries / Q000191:economics; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007194:India; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D019380:Anti-HIV Agents; D016568:Drugs, Generic